Cargando…

The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial

BACKGROUND: Major depressive disorder (MDD) is a high risk factor for suicide, with up to 20% of MDD patients attempting suicide during their lifetime. Current treatments for MDD are slow onset of action, low efficiency, and the inability to control suicidal behaviors quickly and effectively. Intrav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Haiyan, Lan, Xiaofeng, Wang, Chengyu, Zhang, Fan, Fu, Ling, Li, Weicheng, Ye, Yanxiang, Hu, Zhibo, Chao, Ziyuan, Ning, Yuping, Zhou, Yanling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710171/ https://www.ncbi.nlm.nih.gov/pubmed/36451150 http://dx.doi.org/10.1186/s12888-022-04388-y

Ejemplares similares

Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial
por: Lan, Xiaofeng, et al.
Publicado: (2023)

Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression
por: Lan, Xiaofeng, et al.
Publicado: (2023)

Aberrant Dynamic Functional Connectivity of Posterior Cingulate Cortex Subregions in Major Depressive Disorder With Suicidal Ideation
por: Li, Weicheng, et al.
Publicado: (2022)

Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation
por: Zhou, Yanling, et al.
Publicado: (2022)

Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder
por: Liu, Haiyan, et al.
Publicado: (2023)

The functional connectivity of the middle frontal cortex predicts ketamine’s outcome in major depressive disorder
por: Zhang, Fan, et al.
Publicado: (2022)

Baseline patterns of resting functional connectivity within posterior default-mode intranetwork associated with remission to antidepressants in major depressive disorder
por: Ye, Yanxiang, et al.
Publicado: (2022)

Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior
por: Canuso, Carla M., et al.
Publicado: (2021)

Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2021)

The core inflammatory factors in patients with major depressive disorder: a network analysis
por: Zeng, Yexian, et al.
Publicado: (2023)

Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
por: Zhou, Yanling, et al.
Publicado: (2021)

The use of esketamine in the treatment of patients with severe depression and suicidal ideation: systematic review and meta-analysis
por: Floriano, Idevaldo, et al.
Publicado: (2023)

Intranasal Esketamine and Current Suicidal Ideation With Intent in Major Depression Disorder: Beat the Clock, Save a Life, Start a Strategy
por: Pompili, Maurizio
Publicado: (2020)

Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials
por: Diekamp, Bettina, et al.
Publicado: (2021)

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality
por: Fu, Dong-Jing, et al.
Publicado: (2023)

Critical appraisal of major depression with suicidal ideation
por: Pompili, Maurizio
Publicado: (2019)

Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
por: Zheng, Wei, et al.
Publicado: (2022)

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
por: Lan, Xiaofeng, et al.
Publicado: (2022)

Suicidal Ideation and Electroconvulsive Therapy: Outcomes in Adolescents With Major Depressive Disorder
por: Cai, Haipeng, et al.
Publicado: (2023)

Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder
por: Zheng, Wei, et al.
Publicado: (2023)

Prevalence of suicidal ideation, suicidal attempt and completed suicide in Ethiopia: a systematic review and meta-analysis protocol
por: Bifftu, Berhanu Boru, et al.
Publicado: (2019)

Sequential bilateral accelerated theta burst stimulation in adolescents with suicidal ideation associated with major depressive disorder: Protocol for a randomized controlled trial
por: Yuruk, Deniz, et al.
Publicado: (2023)

Suicidal ideation and attempts in patients with major depression: Sociodemographic and clinical variables
por: Srivastava, A.S., et al.
Publicado: (2005)

Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
por: Bai, Shunjie, et al.
Publicado: (2021)

Risk of suicide ideation in comorbid substance use disorder and major depression
por: Onaemo, Vivian N., et al.
Publicado: (2022)

Suicidal Ideation in Major Depressed Individuals: Role of Type D Personality
por: Laoufi, Mokhtar Abdelhakim, et al.
Publicado: (2022)

Suicidal Ideations in Major Depressed Subjects: Role of the Temporal Dynamics of Anhedonia
por: Darquennes, Gil, et al.
Publicado: (2023)

Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II)
por: Jamieson, Carol, et al.
Publicado: (2023)

Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone
por: Kern, David M., et al.
Publicado: (2023)

Associations of serum cystatin C with depressive symptoms and suicidal ideation in major depressive disorder
por: Sun, Ting, et al.
Publicado: (2021)

Adapted suicide safety plans to address self-harm, suicidal ideation, and suicide behaviours in autistic adults: protocol for a pilot randomised controlled trial
por: Rodgers, Jacqui, et al.
Publicado: (2023)

Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
por: Ionescu, Dawn F, et al.
Publicado: (2020)

Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder
por: Zhan, Yanni, et al.
Publicado: (2020)

Association between cognitive deficits and suicidal ideation in patients with major depressive disorder
por: Pu, Shenghong, et al.
Publicado: (2017)

Dienogest-induced major depressive disorder with suicidal ideation: A case report
por: Lee, Sang Min, et al.
Publicado: (2021)

Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder
por: Olgiati, Paolo, et al.
Publicado: (2023)

Does lithium reduce acute suicidal ideation and behavior? A protocol for a randomized, placebo-controlled multicenter trial of lithium plus Treatment As Usual (TAU) in patients with suicidal major depressive episode
por: Lewitzka, U., et al.
Publicado: (2015)

SUICIDAL IDEATION AND BIOGENIC AMINES IN DEPRESSION*
por: Palaniappan, V., et al.
Publicado: (1983)

Treating suicidal ideation in the context of depression
por: Schneider, Renee A., et al.
Publicado: (2020)

Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fbimtblcg1df0tn11rv14840rc